Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity
Main Authors: | Ana Maria Da Costa Ferreira, Regine Schneider-Stock, Francesca Aiello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.859821/full |
Similar Items
-
Assessing Anti-Inflammatory Activities and Compounds in Switchgrass (<i>Panicum virgatum</i>)
by: Khanh-Van Ho, et al.
Published: (2022-06-01) -
Novel Copper(II) Complexes with <i>S</i>-Substituted Isothiosemicarbazone as Highly Selective Anticancer Compounds against BxPC-3 Cell Line
by: Vasilii Graur, et al.
Published: (2022-11-01) -
In Vitro Selective Growth-Inhibitory Activities of Phytochemicals, Synthetic Phytochemical Analogs, and Antibiotics against Diarrheagenic/Probiotic Bacteria and Cancer/Normal Intestinal Cells
by: Tomas Kudera, et al.
Published: (2020-09-01) -
Anti-progressive conditions for the functioning of enterprises; innovation in the opinion of producers of technical means of agricultural transport – the context of its implementation and its barriers
by: Przemysław Niewiadomski, et al.
Published: (2023-07-01) -
Developing of enterprise`s anti-crisis program in conditions of innovative development
by: O.Yu. Shilova
Published: (2013-12-01)